Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global AI Market Portraiture
2.2. Global AI Market, by Type of Allergy, 2017 (US$ Mn)
2.3. Global AI Market, by Type of Treatment, 2017 (US$ Mn)
2.4. Global AI Market, by Geography, 2017 Vs 2026 (Value %)
Chapter 3. Global Allergy Immunotherapy (AI) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2017
Chapter 4. Global Allergy Immunotherapy (AI) Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Food Allergy
4.3. Allergic Rhinitis
4.4. Skin Allergy
4.5. Insect-bite Allergy
4.6. Other Allergies (Drug Allergy, Eye Allergy, Latex Allergy, etc.)
Chapter 5. Global Allergy Immunotherapy (AI) Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Subcutaneous Immunotherapy (SCIT)
5.3. Sublingual Immunotherapy (SLIT)
Chapter 6. Global Allergy Immunotherapy (AI) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America AI Market Analysis, 2016 – 2026
6.2.1. North America AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.2.2. North America AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.2.3. North America AI Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe AI Market Analysis, 2016 – 2026
6.3.1. Europe AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.3.2. Europe AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.3.3. Europe AI Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific AI Market Analysis, 2016 – 2026
6.4.1. Asia Pacific AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.4.2. Asia Pacific AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.4.3. Asia Pacific AI Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America AI Market Analysis, 2016 – 2026
6.5.1. Latin America AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.5.2. Latin America AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.5.3. Latin America AI Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) AI Market Analysis, 2016 – 2026
6.6.1. Middle East & Africa AI Market, by Type of Allergy, 2016–2026 (US$ Mn)
6.6.2. Middle East & Africa AI Market, by Type of Treatment, 2016–2026 (US$ Mn)
6.6.3. MEA AI Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. ALK-Abello A/S
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. HAL Allergy Group
7.3. Circassia
7.4. Aimmune Therapeutics
7.5. Merck KGaA
7.6. Anergis
7.7. Biomay AG
7.8. Stallergenes Greer
7.9. DBV Technologies
7.10. Allergy Therapeutics
List of Figures
FIG. 1 : Allergy Immunotherapy (AI): Market Segmentation
FIG. 2 : Global AI Market Share, by Type of Allergy, 2017 (US$ Mn)
FIG. 3 : Global AI Market Share, by Type of Treatment, 2017 (US$ Mn)
FIG. 4 : Global AI Market, by Geography, 2017 Vs 2026 (Value %)
FIG. 5 : Attractive Investment Proposition, by Geography, 2017
FIG. 6 : Market Competition Landscape, by Key Players, 2017
FIG. 7 : Global Food AI Market, 2016 – 2026 (US$ Mn)
FIG. 8 : Global Allergic Rhinitis Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 9 : Global Skin AI Market, 2016 – 2026 (US$ Mn)
FIG. 10 : Global Insect-bite AI Market, 2016 – 2026 (US$ Mn)
FIG. 11 : Global Other Allergies Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 12 : Global Subcutaneous Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 13 : Global Sublingual Immunotherapy Market, 2016 – 2026 (US$ Mn)
FIG. 14 : U.S. AI Market, 2016 – 2026 (US$ Mn)
FIG. 15 : Canada AI Market, 2016 – 2026 (US$ Mn)
FIG. 16 : U.K. AI Market, 2016 – 2026 (US$ Mn)
FIG. 17 : Germany AI Market, 2016 – 2026 (US$ Mn)
FIG. 18 : Rest Of Europe AI Market, 2016 – 2026 (US$ Mn)
FIG. 19 : Japan AI Market, 2016 – 2026 (US$ Mn)
FIG. 20 : China AI Market, 2016 – 2026 (US$ Mn)
FIG. 21 : Rest Of Asia Pacific AI Market, 2016 – 2026 (US$ Mn)
FIG. 22 : Brazil AI Market, 2016 – 2026 (US$ Mn)
FIG. 23 : Mexico AI Market, 2016 – 2026 (US$ Mn)
FIG. 24 : Rest Of Latin America AI Market, 2016 – 2026 (US$ Mn)
FIG. 25 : GCC AI Market, 2016 – 2026 (US$ Mn)
FIG. 26 : Rest Of Middle East And Africa AI Market, 2016 – 2026 (US$ Mn)
List of Tables
TABLE 1 : Global Allergy Immunotherapy (AI) Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 2 : Global AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 3 : North America AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 4 : North America AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 5 : North America AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 6 : Europe AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 7 : Europe AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 8 : Europe AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 9 : Asia Pacific AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 10 : Asia Pacific AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 11 : Asia Pacific AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 : Latin America AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 13 : Latin America AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 14 : Latin America AI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 : Middle East & Africa AI Market, by Type of Allergy, 2016 – 2026 (US$ Mn)
TABLE 16 : Middle East & Africa AI Market, by Type of Treatment, 2016 – 2026 (US$ Mn)
TABLE 17 : Middle East And Africa AI Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 18 : ALK-Abello A/S: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 : Stallergenes Greer: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 : DBV Technologies: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 : Allergy Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 : HAL Allergy Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 : Circassia: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 : Aimmune Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 : Merck KGaA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 : Anergis: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 : Biomay AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)